APA

Varghese L., Talbot L., Govender A., Zhang X. & Mungall B. A. (20190819). A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. : Applied health economics and health policy.

Chicago

Varghese Lijoy, Talbot Louise, Govender Andrea, Zhang Xu-Hao and Mungall Bruce A. 20190819. A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. : Applied health economics and health policy.

Harvard

Varghese L., Talbot L., Govender A., Zhang X. and Mungall B. A. (20190819). A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. : Applied health economics and health policy.

MLA

Varghese Lijoy, Talbot Louise, Govender Andrea, Zhang Xu-Hao and Mungall Bruce A. A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand. : Applied health economics and health policy. 20190819.